Diagnosis and Differential Diagnosis
Serum Glutamate Is a Predictor for the Diagnosis of Multiple Sclerosis.
Al Gawwam G,Sharquie IK.ScientificWorldJournal.2017;2017:9320802. doi: 10.1155/2017/9320802. Epub 2017 Jun 6.
Vogt Koyanagi Harada Syndrome mimickingmultiple sclerosis: A case report and review of the literature.
Algahtani H,Shirah B,Algahtani R,Alkahtani A,Alwadie S.MultSclerRelatDisord.2017 Feb;12:44-48. doi: 10.1016/j.msard.2017.01.003. Epub 2017 Jan 6.
Sensitivity of visual evoked potentials and spectral domain optical coherence tomography in early relapsing remittingmultiple sclerosis.
Behbehani R,Ahmed S,Al-Hashel J,Rousseff RT,Alroughani R.MultSclerRelatDisord.2017 Feb; 12:15-19. doi: 10.1016/j.msard.2016.12.005. Epub 2016 Dec 23.
Epidemiology and Risk Factors
Cytomegalovirus and varicella zoster virus seropositivity of Iranian patients withmultiple sclerosis: A population-based study.
Karampoor S,Zahednasab H,Ramagopalan S,Mehrpour M,Etemadifar M,Alsahebfosoul F,Keyvani H.J Neuroimmunol.2017 Aug 15;309:4-6. doi: 10.1016/j.jneuroim.2017.04.004. Epub 2017 Apr 8.
Multiple sclerosis-associated retrovirus, Epstein-Barr virus, and vitamin D status in patients with relapsing remittingmultiple sclerosis.
Mostafa A,Jalilvand S,Shoja Z,Nejati A,Shahmahmoodi S,Sahraian MA,Marashi SM.J Med Virol.2017 Jul;89(7):1309-1313. doi: 10.1002/jmv.24774. Epub 2017 Mar 8.
Relationship of Human Herpes Virus 6 andMultiple Sclerosis: A Systematic Review and Meta-analysis.
Pormohammad A,Azimi T,Falah F,Faghihloo E. J Cell Physiol.2017 Jun 20. doi: 10.1002/jcp.26000. [Epub ahead of print]
Determining the IgM and IgG Antibody titer against CMV and helicobacter pylori in the serum of multiple sclerosis patients comparing to the control group in Hamadan.
Salim MA,Eftekharian MM,Taheri M,Yousef Alikhani M.Hum Antibodies.2017 May 5. doi: 10.3233/HAB-170317. [Epub ahead of print]
Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran.
Eskandarieh S,Heydarpour P,Elhami SR,Sahraian MA.Iran J Public Health.2017 May;46(5):699-704.
Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy.Ghasemi N,Razavi S,Nikzad E.Cell J.2017 Apr-Jun;19(1):1-10. Epub 2016 Dec 21.
Human herpes virus 6 status in relapsing-remittingmultiple sclerosispatients.
Nejati A,Shoja Z,Farahmand M,Shahmahmoodi S,Akrami K,Hamid KM,Tafakhori A,Doosti R,Sahraian MA,Marashi SM.Intern Med J.2017 Mar;47(3):339-341. doi: 10.1111/imj.13363.
Multiple sclerosisamong Afghan immigrants in Isfahan,Iran.
Etemadifar M,Sadeghpour N,Nekouie K,Jahansouz M,Salari M,Fereidan-Esfahani M.MultSclerRelatDisord.2017 Apr;13:52-57. doi: 10.1016/j.msard.2017.02.006. Epub 2017 Feb 7.
Fastmultiple sclerosisprogression in North Africans: Both genetics and environment matter.
Sidhom Y,Maillart E,Tezenas du Montcel S,Kacem I,Lubetzki C,Gouider R,Papeix C.Neurology.2017 Mar 28;88(13):1218-1225. doi: 10.1212/WNL.0000000000003762. Epub 2017 Feb 24.
Multiple sclerosisand air pollution exposure: Mechanisms toward brain autoimmunity.
Esmaeil Mousavi S1,Heydarpour P2,Reis J3,Amiri M1,Sahraian MA4. Med Hypotheses.2017 Mar;100:23-30. doi: 10.1016/j.mehy.2017.01.003. Epub 2017 Jan 11.
Comparing epidemiology and baseline characteristic ofmultiple sclerosisand neuromyelitisoptica: A case-control study.
Eskandarieh S,Nedjat S,Abdollahpour I,Moghadasi AN,Azimi AR,Sahraian MA. MultSclerRelatDisord.2017 Feb; 12:39-43. doi: 10.1016/j.msard.2017.01.004. Epub 2017 Jan 6.
Immunology and Pathology
Determination of cytokine levels inmultiple sclerosispatients and their relevance with patients' response to Cinnovex.
Taheri M,Ghafouri-Fard S,Solgi G,Sayad A,Mazdeh M,Omrani MD. Cytokine.2017 Aug;96:138-143. doi: 10.1016/j.cyto.2017.04.007. Epub 2017 Apr 9.
Effect of vitamin D replacement on immunological biomarkers in patients withmultiple sclerosis.
Mrad MF,El Ayoubi NK,Esmerian MO,Kazan JM,Khoury SJ.
ClinImmunol.2017 Aug;181:9-15. doi: 10.1016/j.clim.2017.05.017. Epub 2017 May 20.
Effect of aerobic interval training on serum IL-10, TNFα, and adipokines levels in women withmultiple sclerosis: possible relations with fatigue and quality of life.
Mokhtarzade M,Ranjbar R,Majdinasab N,Patel D,MolanouriShamsi M.Endocrine.2017 Aug;57(2):262-271. doi: 10.1007/s12020-017-1337-y. Epub 2017 Jun 14.
Concerning the article "Interleukins 17 and 10 in a sample of Egyptian relapsing remittingmultiple sclerosispatients".
Tawfik TZ,Gad AH,Mehaney DA,El Nahrery E,Shehata HS,Hashem H,Abdel Ghaffar NF,Shalaby N. J Neurol Sci.2017 Jul 15;378:152. doi: 10.1016/j.jns.2017.04.043. Epub 2017 Apr 26.
Ginger Extract Modulates the Expression of Chemokines CCL20 and CCL22 and Their Receptors (CCR6 and CCR4) in the Central Nervous System of Mice with Experimental Autoimmune Encephalomyelitis.
Jafarzadeh A,Arabi Z,Ahangar-Parvin R,Mohammadi-Kordkhayli M,Nemati M.Drug Res (Stuttg).2017 Jul 3. doi: 10.1055/s-0043-113455. [Epub ahead of print]
Interleukin 17 and 10 in relapsing remitting multiple sclerosis.
Farrokhi M,Masoudifar A,Peykanpour F.J Neurol Sci.2017 Jul 15;378:63. doi: 10.1016/j.jns.2017.04.044. Epub 2017 Apr 26.
The expression of VDR mRNA but not NF-κB surprisingly decreased after vitamin D treatment in multiple sclerosis patients.
Shirvani-Farsani Z,Kakhki MP,Gargari BN,Doosti R,Moghadasi AN,Azimi AR,Behmanesh M. Neurosci Lett.2017 Jul 13;653:258-263. doi: 10.1016/j.neulet.2017.05.050. Epub 2017 May 30.
Altered expression of IGF-I system in neurons of the inflamed spinal cord during acute experimental autoimmune encephalomyelitis.
ParvanehTafreshi A,Talebi F,Ghorbani S,Bernard C,Noorbakhsh F.J Comp Neurol.2017 Jun 15. doi: 10.1002/cne.24263. [Epub ahead of print]
Role of Mast Cells in the Pathogenesis ofMultiple Sclerosisand Experimental Autoimmune Encephalomyelitis.
Elieh-Ali-Komi D,Cao Y.Clin Rev Allergy Immunol.2017 Jun;52(3):436-445. doi: 10.1007/s12016-016-8595-y.
Association of the IL-10 receptor A536G (S138G) loss-of-function variant withmultiple sclerosisin Tunisian patients.
Ben Fredj N,Aissi M,Ben Selma W,Mahmoud I,Nefzi F,Frih-Ayed M,Boukadida J,Aouni M.APMIS.2017 May;125(5):444-451. doi: 10.1111/apm.12659. Epub 2017 Feb 22.
Investigating the exon 6 sequence changes of interleukin 7 receptor A (IL7RA) gene in patients with relapsing-remitting multiple sclerosis.
Taheri M,Sayad A.Hum Antibodies.2017 May 12. doi: 10.3233/HAB-170320. [Epub ahead of print]
Phospholipase D1 expression analysis in relapsing-remittingmultiple sclerosispatients.
Eftekharian MM,Azimi T,Ghafouri-Fard S,Sayad A,Omrani MD,Sarrafzadeh S,Abbasalipourkabir R,Mazdeh M,Taheri M.Neurol Sci.2017 May;38(5):865-872. doi: 10.1007/s10072-017-2857-1. Epub 2017 Feb 22.
Soluble CD40 ligand derived from serum is not correlated with early MS.
Zahednasab H,Siroos B,Balood M,Aleagha MSE,Harirchian MH.MultSclerRelatDisord.2017 May;14:29-31. doi: 10.1016/j.msard.2016.11.004. Epub 2016 Nov 10.
The neuroprotective effect of mesenchymal stem cells on an experimentally induced model formultiple sclerosisin mice.
Mahfouz MM,Abdelsalam RM,Masoud MA,Mansour HA,Ahmed-Farid OA,Kenawy SA.
J BiochemMolToxicol.2017 May 29. doi: 10.1002/jbt.21936. [Epub ahead of print].
Assessment of plasma biomarkers for their association withMultiple Sclerosisprogression.
Jacob S,Al-Kandari A,Alroughani R,Al-Temaimi R.J Neuroimmunol.2017 Apr 15;305:5-8. doi: 10.1016/j.jneuroim.2017.01.008. Epub 2017 Jan 13.
Development and Pre-Clinical Evaluation of Recombinant Human Myelin Basic Protein Nano Therapeutic Vaccine in Experimental Autoimmune Encephalomyelitis Mice Animal Model.
Al-Ghobashy MA,ElMeshad AN,Abdelsalam RM,Nooh MM,Al-Shorbagy M,Laible G.
Sci Rep.2017 Apr 2017:46468. doi: 10.1038/srep46468.
Decreased expression of Sema3A, an immune modulator, in blood sample ofmultiple sclerosispatients.
Rezaeepoor M,Shapoori S,Ganjalikhani-Hakemi M,Etemadifar M,Alsahebfosoul F,Eskandari N,Mansourian M. Gene.2017 Apr 30;610:59-63. doi: 10.1016/j.gene.2017.02.013. Epub 2017 Feb 7.
IFNAR1 expression level in Iranianmultiple sclerosispatients treated with IFN-B.
Sayad A,Kelarijani MK,Sajjadi E,Taheri M.Hum Antibodies.2017 Mar 3. doi: 10.3233/HAB-170316. [Epub ahead of print]
The Association of Interleukin-16 Gene Polymorphisms with IL-16 Serum Levels and Risk ofMultiple Sclerosis.
Farrokhi M,Masoudifar A,Derakhshan A,Saadatmand S,Rouhi-Boroujeni H,Etemadifar M,Rezaei-Zarji S,Javid A,Nobakht R,Deyhimi M,Ekramnia A,Ebrahimi M,Sheikh S,AnsaripourS,Amani-Beni A,Jahanbani-Ardakani H. Immunol Invest.2017 Feb 2:1-9. doi: 10.1080/08820139.2016.1268154. [Epub ahead of print]
Genetics
Correlation between heavy metal exposure and GSTM1 polymorphism in Iranianmultiple sclerosispatients.
Aliomrani M,Sahraian MA,Shirkhanloo H,Sharifzadeh M,Khoshayand MR,Ghahremani MH. Neurol Sci.2017 Jul;38(7):1271-1278. doi: 10.1007/s10072-017-2934-5. Epub 2017 Apr 21.
Myxovirus resistance protein A (MxA) polymorphism is associated with IFNβ response in Iranianmultiple sclerosispatients.
Sayad A,Ghafouri-Fard S,Omrani MD,Noroozi R,Taheri M.Neurol Sci.2017 Jun;38(6):1093-1099. doi: 10.1007/s10072-017-2935-4. Epub 2017 Apr 6.
A Nanobiosensor Based on Fluorescent DNA-Hosted Silver Nanocluster and HCR Amplification for Detection of MicroRNA Involved in Progression of Multiple Sclerosis.
Mansourian N,Rahaie M,Hosseini M.J Fluoresc.2017 May 6. doi: 10.1007/s10895-017-2105-3. [Epub ahead of print]
An interleukin 12 B single nucleotide polymorphism increases IL-12p40 production and is associated with increased disease susceptibility in patients with relapsing-remittingmultiple sclerosis.
Javan MR,Shahraki S,Safa A,Zamani MR,Salmaninejad A,Aslani S.Neurol Res.2017 May;39(5):435-441. doi: 10.1080/01616412.2017.1301623. Epub 2017 Mar 9.
Association of rs1738074 polymorphism of TAGAP gene with susceptibility tomultiple sclerosisin the Iranian population.
Jazaeri A,Vallian S.Neurosci Lett.2017 May 1;648:66-69. doi: 10.1016/j.neulet.2017.03.041. Epub 2017 Mar 27.
PLXNA3 Variant rs5945430 is Associated with Severe Clinical Course in MaleMultiple SclerosisPatients.
Qureshi M,Hatem M,Alroughani R,Jacob SP,Al-Temaimi RA.Neuromolecular Med.2017 May 23. doi: 10.1007/s12017-017-8443-0. [Epub ahead of print]
The Importance of VEGF-KDR Signaling Pathway Genes should Not Be Ignored When the Risk of DevelopingMultiple Sclerosisis Taken into Consideration.
Mazdeh M,Noroozi R,Gharesouran J,Sayad A,Komaki A,Eftekharian MM,Habibi M,Toghi M,Taheri M. J MolNeurosci.2017 May;62(1):73-78. doi: 10.1007/s12031-017-0912-2. Epub 2017 Apr 11.
Epigenetic and gene expression alterations of FOXP3 in the T cells of EAE mouse model ofmultiple sclerosis.
Noori-Zadeh A,Mesbah-Namin SA,Saboor-Yaraghi AA.J Neurol Sci.2017 Apr 15;375:203-208. doi: 10.1016/j.jns.2017.01.060. Epub 2017 Jan 24.
Novel functional polymorphism in IGF-1 gene associated withmultiple sclerosis: A new insight to MS.
Shahbazi M,Abdolmohammadi R,Ebadi H,Farazmandfar T.MultSclerRelatDisord.2017 Apr;13:33-37. doi: 10.1016/j.msard.2017.02.002. Epub 2017 Feb 4.
SOCS gene family expression profile in the blood ofmultiple sclerosispatients.
Toghi M,Taheri M,Arsang-Jang S,Ohadi M,Mirfakhraie R,Mazdeh M,Sayad A. J Neurol Sci.2017 Apr 15;375:481-485. doi: 10.1016/j.jns.2017.02.015. Epub 2017 Feb 9.
MicroRNA-142 regulates inflammation and T cell differentiation in an animal model ofmultiple sclerosis.
Talebi F,Ghorbani S,Chan WF,Boghozian R,Masoumi F,Ghasemi S,Vojgani M,Power C,Noorbakhsh F. J Neuroinflammation.2017 Mar 16;14(1):55. doi: 10.1186/s12974-017-0832-7.
Mitochondrial DNA G13708A variation andmultiple sclerosis: Is there an association?
Andalib S,Talebi M,Sakhinia E,Farhoudi M,Sadeghi-Bazargani H,Emamhadi MR,Masoodian N,Balaghi-Inalou M,Vafaee MS,Gjedde A. Rev Neurol (Paris).2017 Mar;173(3):164-168. doi: 10.1016/j.neurol.2017.02.002. Epub 2017 Mar 22.
Polymorphisms of RPS6KB1 and CD86 associates with susceptibility tomultiple sclerosisin Iranian population.
AbdollahZadeh R,Jalilian N,Sahraian MA,Kasraian Z,Noori-Daloii MR.Neurol Res.2017 Mar;39(3):217-222. doi: 10.1080/01616412.2016.1278108. Epub 2017 Jan 12.
The expression of lnc-IL-7R long non-coding RNA dramatically correlated with soluble and membrane-bound isoforms of IL-7Ra gene inmultiple sclerosispatients.
Bina P,PahlevanKakhki M,Sahraian MA,Behmanesh M.Neurosci Lett.2017 Mar 6;642:174-178. doi: 10.1016/j.neulet.2017.01.068. Epub 2017 Feb 4.
Inverse Relation between MxA Gene Expression and Age inMultiple SclerosisPatients Reveals a Gender Difference in Response to Interferon Therapy.
Taheri M,Mirinezhad M,Omrani MD,Sajjadi E,Inoko H,Sayad A.IranJ Allergy Asthma Immunol.2017 Feb;16(1):21-27.
Clinical Aspects
Depression, anxiety and stress severities inmultiple sclerosispatients using injectable versus oral treatments.
Al-Hussain F,Al-Salloum N,Alazwary N,Saeedi J,Howaidi S,Daif A.J Comp Eff Res.2017 Jul 12. doi: 10.2217/cer-2016-0087. [Epub ahead of print]
Somatosensory impairment and its association with balance limitation in people withmultiple sclerosis.
Jamali A,Sadeghi-Demneh E,Fereshtenajad N,Hillier S. Gait Posture.2017 Jun 24;57:224-229. doi: 10.1016/j.gaitpost.2017.06.020. [Epub ahead of print]
The Relationship between Psychosocial Factors and Cognition inMultiple Sclerosis.
Alosaimi FD,AlMulhem A,Moscovici M,AlShalan H,Alqazlan M,Aldaif A,Sockalingam S.Behav Neurol.2017;2017:6847070. doi: 10.1155/2017/6847070. Epub 2017 May 6.
Effect of Vitamin D Replacement on Cognition inMultiple SclerosisPatients.
Darwish H,Haddad R,Osman S,Ghassan S,Yamout B,Tamim H,Khoury S.Sci Rep.2017 Apr 4;7:45926. doi: 10.1038/srep45926.
Fatigue inmultiple sclerosis- Insights into evaluation and management.
Ayache SS,Chalah MA.NeurophysiolClin.2017 Apr;47(2):139-171. doi: 10.1016/j.neucli.2017.02.004. Epub 2017 Apr 23.
Neuromyelitisoptica spectrum disease characteristics in Isfahan,Iran: A cross-sectional study.
Ashtari F,Safaei A,Shaygannejad V,Najafi MA,Vesal S. J Res Med Sci.2017 Mar 15;22:41. doi: 10.4103/1735-1995.202142. eCollection 2017.
Sexual dysfunction levels in iranian women suffering frommultiple sclerosis.
Dehghan-Nayeri N,Khakbazan Z,Ghafoori F,Nabavi SM.MultSclerRelatDisord.2017 Feb;12:49-53. doi: 10.1016/j.msard.2017.01.005. Epub 2017 Jan 6.
Neuroimaging
Neural Network-Based Learning Kernel for Automatic Segmentation of Multiple Sclerosis Lesions on Magnetic Resonance Images.
Khastavaneh H,Ebrahimpour-Komleh H.J Biomed Phys Eng.2017 Jun 1;7(2):155-162. eCollection 2017 Jun.
Assessment of the diagnostic accuracy of double inversion recovery sequence compared with FLAIR and T2W_TSE in detection of cerebralmultiple sclerosislesions.
Abidi Z,Faeghi F,Mardanshahi Z,Mortazavi H.Electron Physician.2017 Apr 25;9(4):4162-4170. doi: 10.19082/4162. eCollection 2017 Apr.
Optical coherence tomography segmentation analysis in relapsing remitting versus progressivemultiple sclerosis.
Behbehani R,Abu Al-Hassan A,Al-Salahat A,Sriraman D,Oakley JD,Alroughani R.PLoS One.2017 Feb 13;12(2):e0172120. doi: 10.1371/journal.pone.0172120. eCollection 2017.
MS Therapies
Fluvoxamine stimulates oligodendrogenesis of cultured neural stem cells and attenuates inflammation and demyelination in an animal model ofmultiple sclerosis.
Ghareghani M,Zibara K,Sadeghi H,Dokoohaki S,Sadeghi H,Aryanpour R,Ghanbari A.Sci Rep.2017 Jul 7;7(1):4923. doi: 10.1038/s41598-017-04968-z.
Modulation of sphingosine-1-phosphate receptor ameliorates harmaline-induced essential tremor in rat.
Dahmardeh N,Asadi-Shekaari M,Arjmand S,Kalantaripour T,Basiri M,Shabani M.Neurosci Lett.2017 Jul 13;653:376-381. doi: 10.1016/j.neulet.2017.06.015. Epub 2017 Jun 13.
Pulmonary Nocardiabeijingensis infection associated with the use of alemtuzumab in a patient withmultiple sclerosis.
Sheikh-Taha M,Corman LC.MultScler.2017 May;23(6):872-874. doi: 10.1177/1352458517694431. Epub 2017 Feb 1.
The Use of Natalizumab in Pediatric Patients With Active RelapsingMultiple Sclerosis: A Prospective Study.
Alroughani R,Ahmed SF,Behbehani R,Al-Hashel J.Pediatr Neurol.2017 May;70:56-60. doi: 10.1016/j.pediatrneurol.2017.01.017. Epub 2017 Feb 2.
Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitisoptica spectrum disorder.
Yamout BI,Beaini S,Zeineddine MM,Akkawi N.MultScler.2017 Apr 1:1352458517694086. doi: 10.1177/1352458517694086. [Epub ahead of print]
Immunomodulatory properties of human placental mesenchymal stem/stromal cells.
Abumaree MH,Abomaray FM,Alshabibi MA,AlAskar AS,Kalionis B.Placenta.2017 Apr 7. pii: S0143-4004(17)30225-4. doi: 10.1016/j.placenta.2017.04.003. [Epub ahead of print]
Psychosocial predictors of patient adherence to disease-modifying therapies formultiple sclerosis.
Alosaimi FD,AlMulhem A,AlShalan H,Alqazlan M,Aldaif A,Kowgier M,Balasundaram J,Sockalingam S.Patient Prefer Adherence.2017 Mar 9;11:513-518. doi: 10.2147/PPA.S129678. eCollection 2017.
Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues forMultiple Sclerosis.
Motavaf M,Sadeghizadeh M,Javan M.Cell MolNeurobiol.2017 Feb 21. doi: 10.1007/s10571-017-0472-6. [Epub ahead of print]
Efficacy and safety of rituximab in neuromyelitisoptica: Review of evidence.
Etemadifar M,Salari M,Mirmosayyeb O,Serati M,Nikkhah R,Askari M,Fayyazi E.J Res Med Sci.2017 Feb 16;22:18. doi: 10.4103/1735-1995.200275. eCollection 2017.
Intrathecal Injection of Peripherally Mobilized Blood Stem Cells to TreatMultiple Sclerosis.
Hammadi AM,Al-Himyari FA.ExpClin Transplant.2017 Feb; 15(Suppl 1):147-149.
Multiple sclerosis: Therapeutic applications of advancing drug delivery systems.
Dolati S,Babaloo Z,Jadidi-Niaragh F,Ayromlou H,Sadreddini S,Yousefi M.Biomed Pharmacother.2017 Feb;86:343-353. doi: 10.1016/j.biopha.2016.12.010. Epub 2016 Dec 21.
Pediatric MS
Clinical and Epidemiological Aspects ofMultiple Sclerosisin Children.
Nasehi MM,Sahraian MA,NaserMoghadasi A,Ghofrani M,Ashtari F,Taghdiri MM,Tonekaboni SH,Karimzadeh P,Afshari M,Moosazadeh M.IranJ Child Neurol.2017 Spring;11(2):37-43.
TumefactiveMultiple SclerosisVariants: Report of Two Cases of Schilder and Balo Diseases.
Ashrafi MR,Tavasoli AR,Alizadeh H,ZareNoghabi J,Parvaneh N.IranJ Child Neurol.2017 Spring;11(2):69-77.
Others
Effect of exercise therapy on quality of life of patients withmultiple sclerosisinIran: a systematic review and meta-analysis.
Afkar A,Ashouri A,Rahmani M,EmamiSigaroudi A.Neurol Sci.2017 Jul 7. doi: 10.1007/s10072-017-3047-x. [Epub ahead of print]
Comparing the effect of Cawthorne-Cooksey and Frenkel exercises on balance in patients withmultiple sclerosis: a randomized controlled trial.
Afrasiabifar A,Karami F,NajafiDoulatabad S.ClinRehabil.2017 Jun 1:269215517714592. doi: 10.1177/0269215517714592. [Epub ahead of print]
Cortical excitability changes: A mirror to the natural history ofmultiple sclerosis?
Ayache SS,Chalah MA.NeurophysiolClin.2017 Jun;47(3):221-223. doi: 10.1016/j.neucli.2017.02.001. Epub 2017 May 4.
Effect of a Couples' Relationship Enrichment Program on the Quality of Marital Relationships from the Perspective of Spouses of Patients withMultiple Sclerosis.
Navidian A,Rezaee N,Baniasadi F,Shakiba M.Issues Ment Health Nurs.2017 Jun 29:1-7. doi: 10.1080/01612840.2017.1294221. [Epub ahead of print]
Perspectives and Experiences Related to Help-Seeking Behaviors: A Content Analysis Study of Iranian Patients With Multiple Sclerosis.
Rabiei L,Abedi H,Abedi P,Zarea K,Masoudi R. J Nurs Res.2017 Jun;25(3):251-259. doi: 10.1097/JNR.0000000000000216.
Informal Caregivers' Experiences of Caring ofMultiple SclerosisPatients: A Qualitative Study.
Gafari S,Khoshknab MF,Nourozi K,Mohamadi E.IranJ Nurs Midwifery Res.2017 May-Jun;22(3):243-247. doi: 10.4103/1735-9066.208168.
Relationship between Neutrophil-to-Lymphocyte Ratio and Stress inMultiple SclerosisPatients.
Al-Hussain F,Alfallaj MM,Alahmari AN,Almazyad AN,Alsaeed TK,Abdurrahman AA,Murtaza G,Bashir S.J ClinDiagn Res.2017 May;11(5):CC01-CC04. doi: 10.7860/JCDR/2017/24388.9764. Epub 2017 May 1.
The Effect of Continuous Care on the Lifestyle of Patients withMultiple Sclerosis: A Randomized Clinical Trial.
Khodaveisi M,Ashtarani F,Beikmoradi A,Mohammadi N,Mahjub H,Mazdeh M,Ashtarani E. IranJ Nurs Midwifery Res.2017 May-Jun;22(3):225-231. doi: 10.4103/1735-9066.208170.
The Relationship Between Religious Beliefs and Quality of Life Among Patients With Multiple Sclerosis.
Vizehfar F,Jaberi A. J Relig Health.2017 May 13. doi: 10.1007/s10943-017-0411-3. [Epub ahead of print]
Tumefactive demyelinating lesions: A comprehensive review.
Algahtani H,Shirah B,Alassiri A.MultSclerRelatDisord.2017 May;14:72-79. doi: 10.1016/j.msard.2017.04.003. Epub 2017 Apr 9.
A comparison the effects of reflexology and relaxation on the psychological symptoms in women with multiple sclerosis.
Soheili M,Nazari F,Shaygannejad V,Valiani M.J Educ Health Promot.2017 Apr 19;6:11. doi: 10.4103/jehp.jehp_166_14. eCollection 2017.
A study of stigma among Iranian family caregivers of patients withmultiple sclerosis: A descriptive explorative qualitative study.
Masoudi R,Khayeri F,Rabiei L,Zarea K.ApplNurs Res.2017 Apr;34:1-6. doi: 10.1016/j.apnr.2016.11.012. Epub 2016 Nov 22.
Perspectives and Experiences Related to Help-Seeking Behaviors: A Content Analysis Study of Iranian Patients WithMultiple Sclerosis.
Rabiei L,Abedi H,Abedi P,Zarea K,Masoudi R.J Nurs Res.2017 Apr 19. doi: 10.1097/jnr.0000000000000216. [Epub ahead of print]
The effect of electronic education on knowledge of patients with multiple sclerosis.
Mohamadirizi S,Shaygannejad V,Mohamadirizi S,Tolou-Ghamari Z.J Educ Health Promot.2017 Apr 19;6:10. doi: 10.4103/jehp.jehp_144_14. eCollection 2017.
The survey of mindfulness in multiple sclerosis patients and its association with attachment style.
Mohamadirizi S,Shaygannejad V,Mohamadirizi S. J Educ Health Promot.2017 Apr 19;6:7. doi: 10.4103/jehp.jehp_114_14. eCollection 2017.
Validity and reliability of the multidimensional assessment of fatigue scale in Iranian patients with relapsing-remitting subtype ofmultiple sclerosis.
Behrangrad S,KordiYoosefinejad A. DisabilRehabil.2017 Mar 21:1-5. doi: 10.1080/09638288.2016.1271024. [Epub ahead of print]
The association between physical activity and sleep characteristics in people withmultiple sclerosis.
Aburub A,Khalil H,Al-Sharman A,Alomari M,Khabour O.MultSclerRelatDisord.2017 Feb; 12:29-33. doi: 10.1016/j.msard.2016.12.010. Epub 2016 Dec 23.
The effect of yoga training on enhancement of Adrenocorticotropic hormone (ACTH) and cortisol levels in female patients withmultiple sclerosis.
Najafi P,Moghadasi M.Complement TherClinPract.2017 Feb;26:21-25. doi: 10.1016/j.ctcp.2016.11.006. Epub 2016 Nov 12.
The impact of disease characteristics onmultiple sclerosispatients' quality of life.
Rezapour A,Almasian Kia A,Goodarzi S,Hasoumi M,NouraeiMotlagh S,Vahedi S. Epidemiol Health.2017 Feb 19;39:e2017008. doi: 10.4178/epih.e2017008. eCollection 2017.
Translation, cross-cultural adaptation and validation of the Persian version of COOP/WONCA charts in Persian-speaking Iranians withmultiple sclerosis.
Taghipour M,Salavati M,Nabavi SM,Akhbari B,EbrahimiTakamjani I,Negahban H,Rajabzadeh F.DisabilRehabil.2017 Feb 21:1-6. doi: 10.1080/09638288.2016.1261420. [Epub ahead of print]